Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Anesthesia vs Sedoanalgesia for Botox in Overactive Bladder
NCT06437899Enrolling by invitation
- Sponsor
- LKH Hochsteiermark Leoben
- Start
- Sep 2023
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine in procedural pain (2 arms), sponsored by LKH Hochsteiermark Leoben. Primary endpoint: pain assessed by numeric rating scale at 24 hours. Started Sep 2023; status: enrolling by invitation.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT06437899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06437899.